arformoterol nebulized
Selected indexed studies
- FULFIL Trial: Once-Daily Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease. (Am J Respir Crit Care Med, 2017) [PMID:28375647]
- Albuterol-Budesonide Fixed-Dose Combination Rescue Inhaler for Asthma. (N Engl J Med, 2022) [PMID:35569035]
- Health resource utilization for inpatients with COPD treated with nebulized arformoterol or nebulized formoterol. (Int J Chron Obstruct Pulmon Dis, 2017) [PMID:28694692]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Predictors of Nebulized Arformoterol Treatment: A Retrospective Analysis of Medicare Beneficiaries with Chronic Obstructive Pulmonary Disease. (2019) pubmed
- Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial. (2007) pubmed
- Controlled Trial of Budesonide-Formoterol as Needed for Mild Asthma. (2019) pubmed
- FULFIL Trial: Once-Daily Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease. (2017) pubmed
- Albuterol-Budesonide Fixed-Dose Combination Rescue Inhaler for Asthma. (2022) pubmed
- Health resource utilization for inpatients with COPD treated with nebulized arformoterol or nebulized formoterol. (2017) pubmed
- Hospital readmissions following initiation of nebulized arformoterol tartrate or nebulized short-acting beta-agonists among inpatients treated for COPD. (2013) pubmed
- Medication management patterns among Medicare beneficiaries with chronic obstructive pulmonary disease who initiate nebulized arformoterol treatment. (2019) pubmed
- Effect of nebulized arformoterol on airway function in COPD: results from two randomized trials. (2008) pubmed
- Compatibility of arformoterol tartrate inhalation solution with three nebulized drugs. (2007) pubmed